AMRI Stock News 15.32 05/13/2014 17:06:13 Albany Molecular Research

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Albany Molecular Research (AMRI) 15.32 $AMRI

Health Care Sector Equities Technical Data -- Research on Albany Molecular Research, Agilent Technologies, Thermo Fisher Scientific, and ICON
PR Newswire - Tue May 13, 8:15AM CDT
The U.S. markets on Monday, May 12, 2014 ended on a positive note as the Dow Jones Industrial Average finished at 16,695.47, up 0.68% and the NASDAQ Composite closed at 4,143.86, up 1.77%. The S&P 500 finished the session 0.97% higher at 1,896.65. During the trading session, eight out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 675.29, up 1.04%, with the index advancing 4.74% in the last one month. Investor-Edge has initiated coverage on the following equities: Albany Molecular Research Inc. (NASDAQ: AMRI), Agilent Technologies Inc. (NYSE: A), Thermo Fisher Scientific Inc. (NYSE: TMO) and ICON PLC (NASDAQ: ICLR). Free technical research on AMRI, A, TMO and ICLR can be downloaded upon signing up at:

AMRI CEO to Present at the UBS Global Healthcare Conference
PR Newswire Europe - Thu May 08, 4:54AM CDT
Albany Molecular Research Inc. announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at the UBS Global Healthcare Conference on Wednesday, May 21, 2014 at 11:00 a.m. ET.

Insider Trading Alert - AMRI, STT And MLNX Traded By Insiders
at The Street - Tue May 06, 12:45PM CDT
Stocks with insider trader activity include AMRI, STT and MLNX

AMRI Announces First Quarter 2014 Results
PR Newswire Europe - Tue May 06, 7:02AM CDT
-- Contract Revenue Growth of 10% to $51.0 Million and Adjusted Diluted EPS of $0.16

AMRI to Announce First Quarter Results
PR Newswire Europe - Tue Apr 22, 7:01AM CDT
AMRI today announced it will issue first quarter financial results before the opening of the market on Tuesday, May 6, 2014. Following the release of its results, the company will host a conference call and simultaneous audio webcast at 10:00 a.m. ET.

NY-based co. closing Syracuse-area lab in July
AP - Thu Apr 17, 10:10AM CDT
CICERO, N.Y. (AP) — An Albany-based pharmaceutical company that's part of a $250 million economic development project in Buffalo is shutting down its Syracuse-area research center, eliminating 45 jobs.

AMRI Realigns Discovery and Development Services to Support Customer Demand
PR Newswire Europe - Wed Apr 16, 8:01AM CDT
AMRI today announced that it will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, N.Y. site to other sites within AMRI and will cease operations in Syracuse by the end of June 2014. The actions taken today are consistent with AMRI's ongoing efforts to consolidate its facility resources to more effectively utilize its discovery and development resource pool and to further reduce its facility cost structure.

Morning Briefing on Top Gainers -- Research on Science Applications Intl., Maxwell Technologies, Albany Molecular Research, and Demandware
PR Newswire - Thu Apr 10, 12:04PM CDT
The US markets saw a positive sentiment on Wednesday, April 09, 2014, with the NASDAQ Composite closing at 4,183.90, up 1.72%, the Dow Jones Industrial Average ending the session at 16,437.18, up 1.11%, and the S&P 500 edging 1.09% higher to finish the trading session at 1,872.18. The session saw a positive impact from Information Technology, Health Care and Materials sectors along with a drag from Utilities and Telecommunication Services sectors. A number of stocks saw large movements, including Science Applications International Corp. (NYSE: SAIC), Maxwell Technologies Inc. (NASDAQ: MXWL), Albany Molecular Research Inc. (NASDAQ: AMRI) and Demandware Inc. (NYSE: DWRE). Free technical research on SAIC, MXWL, AMRI and DWRE can be downloaded upon signing up at:

Financial Results Announcement, Stock Movement, Presentations, and Acquisition - Analyst Notes on Universal Health Services, Tenet, Cynosure, Albany Molecular Research, and Enanta
PR Newswire - Thu Apr 10, 9:49AM CDT
Today, Analysts Review released its analysts' notes regarding Universal Health Services, Inc. (NYSE: UHS), Tenet Healthcare Corp. (NYSE: THC), Cynosure, Inc. (NASDAQ: CYNO), Albany Molecular Research Inc. (NASDAQ: AMRI), and Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Albany Molecular Research (AMRI) Showing Signs Of A Dead Cat Bounce Today
at The Street - Wed Apr 09, 8:59AM CDT
Trade-Ideas LLC identified Albany Molecular Research (AMRI) as a "dead cat bounce" (down big yesterday but up big today) candidate

AMRI Completes Acquisition of Cedarburg Pharmaceuticals, Inc.
PR Newswire Europe - Fri Apr 04, 3:10PM CDT
AMRI today announced that it has completed the previously announced acquisition of Cedarburg Pharmaceuticals, Inc.

Albany Molecular Research Has Returned 52.0% Since SmarTrend Recommendation (AMRI)
Comtex SmarTrend(R) - Fri Apr 04, 9:37AM CDT
SmarTrend identified an Uptrend for Albany Molecular Research (NASDAQ:AMRI) on February 12th, 2014 at $11.62. In approximately 2 months, Albany Molecular Research has returned 51.98% as of today's recent price of $17.66.

Insider Trading Alert - AMRI, CHE And LXK Traded By Insiders
at The Street - Thu Apr 03, 10:45AM CDT
Stocks with insider trader activity include AMRI, CHE and LXK

Albany Molecular Research Shares Up 58.9% Since SmarTrend's Buy Recommendation (AMRI)
Comtex SmarTrend(R) - Fri Mar 28, 9:09AM CDT
SmarTrend identified an Uptrend for Albany Molecular Research (NASDAQ:AMRI) on February 12th, 2014 at $11.62. In approximately 1 month, Albany Molecular Research has returned 58.95% as of today's recent price of $18.47.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 292

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 85

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading
LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 77

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading
Life Insurance: Evolving with Your Financial Journey

Updated Category News Views 56

Why Life Insurance Isn't Just a 'Set It and Forget It' Life insurance isn't some one-time deal you lock in and toss aside. Mike Newell, an insurance pro, highlights how life's shifts—whether in income, dependents, or debt—should drive tweaks to your coverage. As your life story unfolds, so too should the backbone of your financial security. Early Adulthood: Setting...

Continue Reading
Go NYC's Perks: Making Commutes Rewarding in NYC

Updated Category News Views 136

Go NYC's Perks: Turning Commutes into Gains I’ve seen a lot of schemes aimed at getting folks to change their travel habits, but this one from Go NYC caught my attention. These guys are trying to squeeze some extra value out of the daily grind for anyone hoofing it across the Big Apple. A new rewards program named Perks kicks off, offering all kinds of discounts and...

Continue Reading
Better Life Science: Revolutionizing At-Home STI Testing

Updated Category News Views 171

Paving a New Path for STI Testing Accessibility The landscape of STI testing is undergoing a significant shift, and Better Life Science is at the helm with their innovative STD Hero at-home testing service. With a splash in the latest AVN report, they're turning heads in both the clinical world and in mainstream society. This ain't just about checking boxes in health...

Continue Reading
PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 96

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
Cheyenne Real Estate: Neighborhood Nuances and Choices

Updated Category News Views 156

Unearthing the Hidden Dynamics of Cheyenne's Real Estate You've got this picturesque vision in your head of Cheyenne, Wyoming—a sprawling cowboy town with its wild winds and wide-open spaces. But if you think all those neighborhoods are cut from the same cloth, you've got another thing coming. The real estate scene here is just as varied as the prairies stretching out...

Continue Reading
SGRY Acquisition Under Scrutiny: Fairness Questioned

Updated Category News Views 203

Questions Hover Over SGRY Acquisition Here's a real jaw-dropper for you. Surgery Partners, Inc. (NASDAQ: SGRY) is getting clocks cleaned in a fairness probe over its acquisition terms. If you thought this ride was smooth, think again—Levi & Korsinsky, LLP has put the brakes on any such assumptions, launching an investigation that’s sure to raise some eyebrows. What's...

Continue Reading
NVIDIA Faces Turbulent Storm with CEO Resignation

Updated Category News Views 139

Huang's Unexpected Exit and NVIDIA's Rocky Road Well, talk about drama in Silicon Valley. When executives start stumbling, it's not just some PR nightmare—it's a full-on crisis. NVIDIA's co-founder and CEO Jensen Huang is calling it quits, and not on some smooth, idyllic note. No, this is the kind of exit that investors dread. You’ve got affairs, security concerns,...

Continue Reading

Top 5 Most Recently Viewed Articles

Nord Anglia's Private Schools Shine in 2026 National Rankings

Updated Category News Views 363

Nord Anglia's Schools Excel in National Rankings Nord Anglia schools ranked in the top 0.5 to 2% nationally Nord Anglia Education is proud to announce that its schools across the United States have achieved remarkable positions among the leading private schools nationwide, according to the latest Niche rankings for 2026. Unveiling Exceptional Educational Achievements This...

Continue Reading
Ingevity's Leadership Change: New Interim CEO Appointed

Updated Category News Views 151

Ingevity Announces CEO Transition Ingevity Corporation (NYSE: NGVT) has experienced a significant change in its leadership with John Fortson stepping down as president and chief executive officer. Following his departure, the company has entrusted board director Luis Fernandez-Moreno with the role of interim president and CEO while a search is underway for a permanent...

Continue Reading
Projected Growth of Supply Chain Security Market by 2030

Updated Category News Views 165

Growth Prospects of the Supply Chain Security Market The global Supply Chain Security Market is set for significant growth, projected to reach USD 5.14 billion by 2030, up from USD 2.52 billion in 2024. The expected compound annual growth rate (CAGR) during this period is 12.6%, indicating robust expansion in a field that safeguards vital supply chain operations. Scope...

Continue Reading
KLA Corporation's Impressive Fiscal 2026 Q2 Performance Review

Updated Category News Views 249

KLA Corporation's Fiscal 2026 Quarter Two Results Overview KLA Corporation (NASDAQ: KLAC) has reported robust financial results for the second quarter of fiscal year 2026, significantly surpassing expectations. These results underline the company’s powerful position within the semiconductor manufacturing industry. Financial Highlights Revenue Performance The company's...

Continue Reading
Heidi Hunter Steps Up as Vice Chair at Bavarian Nordic Board

Updated Category News Views 152

Heidi Hunter's New Role at Bavarian Nordic Recently, Bavarian Nordic A/S (Copenhagen: BAVA) announced an exciting development by appointing Heidi Hunter as the new Vice Chair of its Board of Directors. This decision follows the recent elevation of Anne Louise Eberhard to Chair, marking a shift in leadership aimed at steering the company forward in the pharmaceutical...

Continue Reading